Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Cancer Genome Atlas Research N, Albert Einstein College of M, analytical biological S, Barretos Cancer H, Baylor College of M, Beckman Research Institute of City of H, Buck Institute for research on a, Canada’s Michael smith genome sciences C, Harvard medical S, Helen FGCC, et al. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378–84.

Article  Google Scholar 

Ward ZJ, Grover S, Scott AM, Woo S, Salama DH, Jones EC, et al. The role and contribution of treatment and imaging modalities in global cervical Li et al. Journal of Experimental & Clinical Cancer Research (2021) 40:150 Page 18 of 20 cancer management: survival estimates from a simulation-based analysis. Lancet Oncol. 2020;21(8):1089–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nin DS, Wujanto C, Tan TZ, Lim D, Damen JMA, Wu KY, Dai ZM, Lee ZW, Idres SB, Leong YH, Jha S, Ng JS, Low JJH, Chang SC, Tan DSP, Wu W, Choo BA, Deng LW. GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibility. Cell Rep. 2021;36(9): 109621.

Article  CAS  PubMed  Google Scholar 

Osawa T, Muramatsu M, Wang F, Tsuchida R, Kodama T, Minami T, Shibuya M. Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesis. Proc Natl Acad Sci USA. 2011;108(51):20725–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu S, Wang X, Yang Y, Li Y, Wu S. LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer. Cell Death Dis. 2021;12(4):282.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin M, Zhang J, Bouamar H, Wang Z, Sun LZ, Zhu X. Fbxo22 promotes cervical cancer progression via targeting p57Kip2 for ubiquitination and degradation. Cell Death Dis. 2022;13(9):805.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiménez-Castillo V, Illescas-Barbosa D, Zenteno E, Ávila-Curiel BX, Castañeda-Patlán MC, Robles-Flores M, De Oca DM, Pérez-Campos E, Torres-Rivera A, Bouaboud A, Pagesy P, Solórzano-Mata CJ, Issad T. Increased O-GlcNAcylation promotes IGF-1 receptor/phosphatidyi inositol-3 kinase/Akt pathway in cervical cancer cells. Sci Rep. 2022;12(1):4464.

Article  PubMed  PubMed Central  Google Scholar 

Zhang D, Grode KD, Stewman SF, Diaz-Valencia JD, Liebling E, Rath U, Riera T, Currie JD, Buster DW, Asenjo AB, Sosa HJ, Ross JL, Ma A, Rogers SL, Sharp DJ. Drosophila katanin is a microtubule depolymerase that regulates cortical-microtubule plus-end interactions and cell migration. Nat Cell Biol. 2011;13(4):361–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mateo J, Lord CJ, Serra V, Tutt A, Balmaña J, Castroviejo-Bermejo M, Cruz C, Oaknin A, Kaye SB, de Bono JS. A decade of clinical development of PARP inhibitors in perspective. Ann Oncol. 2019;30(9):1437–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ray Chaudhuri A, Nussenzweig A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol. 2017;18(10):610–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang D, Kraus WL. The expanding universe of PARP1-mediated molecular and therapeutic mechanisms. Mol Cell. 2022;82(12):2315–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Amours D, Desnoyers S, D’Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J. 1999;342(Pt 2):249–68.

Article  PubMed  PubMed Central  Google Scholar 

Ame JC, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays. 2004;26:882–93.

Article  CAS  PubMed  Google Scholar 

Bouchard VJ, Rouleau M, Poirier GG. PARP-1, a determinant of cell survival in response to DNA damage. Exp Hematol. 2003;31:446–54.

Article  CAS  PubMed  Google Scholar 

Burkle A. Poly(ADP-ribose). The most elaborate metabolite of NAD+. FEBS J. 2005;272:4576–89.

Article  PubMed  Google Scholar 

Yang XD, Kong FE, Qi L, Lin JX, Yan Q, Loong JHC, Xi SY, Zhao Y, Zhang Y, Yuan YF, Ma NF, Ma S, Guan XY, Liu M. PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma. Mol Cancer. 2021;20(1):20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang F, Gouttia OG, Wang L, Peng A. PARP1 upregulation in recurrent oral cancer and treatment resistance. Front Cell Dev Biol. 2022;5(9): 804962.

Article  Google Scholar 

Gilabert M, Launay S, Ginestier C, Bertucci F, Audebert S, Pophillat M, Toiron Y, Baudelet E, Finetti P, Noguchi T, Sobol H, Birnbaum D, Borg JP, Charafe-Jauffret E, Gonçalves A. Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib. PLoS ONE. 2014;9(8): e104302.

Article  PubMed  PubMed Central  Google Scholar 

Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly(ADP-ribose) polymerase-1dependent cell death by apoptosis-inducing factor. Science. 2002;297:259–63.

Article  CAS  PubMed  Google Scholar 

Yu SW, Wang H, Dawson TM, Dawson VL. Poly(ADPribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol Dis. 2003;14:303–17.

Article  CAS  PubMed  Google Scholar 

Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM, et al. Apoptosis-inducing factor mediates poly(ADPribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci USA. 2006;103:18314–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andrabi SA, Kim NS, Yu SW, Wang H, Koh DW, Sasaki M, et al. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci USA. 2006;103:18308–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fossati S, Cipriani G, Moroni F, Chiarugi A. Neither energy collapse nor transcription underlie in vitro neurotoxicity of poly(ADP-ribose) polymerase hyper-activation. Neurochem Int. 2007;50:203–10.

Article  CAS  PubMed  Google Scholar 

Ethier C, Labelle Y, Poirier GG. PARP-1-induced cell death through inhibition of the MEK/ERK pathway in MNNG-treated HeLa cells. Apoptosis. 2007;12(11):2037–49.

Article  CAS  PubMed  Google Scholar